Condition: Bipolar Disorder · Sponsor: Eli Lilly and Company
The purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC), compared with placebo plus SoC in delaying the worsening of bipolar disorder symptoms. The trial is divided into three periods as follows: Screening period that will last approximately 1 month, treatment period that will last a minimum of 6 months, and the follow up period that will last approximately 2 months. The duration of study participation may vary and may be shortened if bipolar symptoms worsen or if withdrawal from the study occurs for any reason.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| ATP Clinical Research | Orange, California, United States | Recruiting |
| Yale University School of Medicine | New Haven, Connecticut, United States | Recruiting |
| AGA Clinical Trials | Hialeah, Florida, United States | Recruiting |
| Accel Research Sites - Maitland Clinical Research Unit | Maitland, Florida, United States | Recruiting |
| K2 Medical Research - Maitland | Maitland, Florida, United States | Recruiting |
| Floridian Clinical Research, LLC | Miami Lakes, Florida, United States | Recruiting |
| CLA Research | Naples, Florida, United States | Recruiting |
| Charter Research - Orlando | Orlando, Florida, United States | Recruiting |
| Encore Medical Research - Weston | Weston, Florida, United States | Recruiting |
| Atlanta Center for Medical Research | Atlanta, Georgia, United States | Recruiting |
| Covenant Medical Center | Waterloo, Iowa, United States | Recruiting |
| CBH Health | Gaithersburg, Maryland, United States | Recruiting |
+ 75 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07286175